Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 9, Issue 1, Pages 27-34
Publisher
Informa UK Limited
Online
2015-10-29
DOI
10.1586/17512433.2016.1100072
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Medications for Treatment of Obesity: Metabolic and Cardiovascular Effects
- (2015) Andrea Pucci et al. CANADIAN JOURNAL OF CARDIOLOGY
- Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
- (2014) Assumpta Caixas et al. Drug Design Development and Therapy
- Metabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment
- (2013) S. R. Kashyap et al. DIABETES CARE
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Anti-obesity drugs: past, present and future
- (2012) R. J. Rodgers et al. Disease Models & Mechanisms
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats
- (2012) Daniel B Kurbanov et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Differential Expression and Sensitivity of Presynaptic and Postsynaptic Opioid Receptors Regulating Hypothalamic Proopiomelanocortin Neurons
- (2011) R. L. Pennock et al. JOURNAL OF NEUROSCIENCE
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Hypothalamic opioid–Melanocortin appetitive balance and addictive craving
- (2010) Albert Stuart Reece MEDICAL HYPOTHESES
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates
- (2009) Eric A. Finkelstein et al. HEALTH AFFAIRS
- Reward systems and food intake: role of opioids
- (2009) B A Gosnell et al. INTERNATIONAL JOURNAL OF OBESITY
- Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
- (2009) Frank L. Greenway et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Naltrexone for the Management of Alcohol Dependence
- (2008) Raymond F. Anton NEW ENGLAND JOURNAL OF MEDICINE
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started